Lv4
444 积分 2024-01-31 加入
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
7天前
已完结
Current evidence and knowledge gaps in family planning and pregnancy in myasthenia gravis, NMOSD, and MOGAD
15天前
已完结
Immune repertoire profiling in myasthenia gravis
21天前
已完结
Anti-CD19 CAR T cells for refractory myasthenia gravis
23天前
已完结
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
23天前
已完结
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
23天前
已完结
Effect of low-dose rituximab treatment on T- and B-cell lymphocyte imbalance in refractory myasthenia gravis
23天前
已完结
B‐cell–activating factor is elevated in serum of patients with myasthenia gravis
23天前
已完结
Disturbed B cell subpopulations and increased plasma cells in myasthenia gravis patients
23天前
已完结
Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis
23天前
已完结
皖公网安备34019202002308
